Lens (anatomy)

National Advertising Division Finds Certain Bausch + Lomb Claims for INFUSE Contact Lenses Supported; Advertiser Appeals Other Findings

Wednesday, December 1, 2021 - 2:00pm

In support of its parity claim, as well as several percentage agreement claims, the advertiser relied on the results of its 893 Clinical Study.

Key Points: 
  • In support of its parity claim, as well as several percentage agreement claims, the advertiser relied on the results of its 893 Clinical Study.
  • NAD noted that the basis for B+L's "most moisture" and "lowest modulus" claims is in vitro testing of the lenses' physical properties.
  • Therefore, NAD recommended that B+L modify its advertising to avoid conveying the message that the physical properties of its INFUSE lenses lead to superior consumer-relevant benefits versus competing lenses, including DT1 lenses.
  • "Such appeals of NAD decisions are made to the BBB National Programs' National Advertising Review Board (NARB), the appellate-level truth-in-advertising body of BBB National Programs.

Hubble Announces Rachael Durkin as Vice President, Marketing & Strategy

Wednesday, December 1, 2021 - 11:00am

NEW YORK, Dec. 1, 2021 /PRNewswire/ -- Vision Path, Inc., the parent company which owns Hubble Contacts and ContactsCart, today named Rachael Durkin as Vice President of Marketing and Strategy.

Key Points: 
  • NEW YORK, Dec. 1, 2021 /PRNewswire/ -- Vision Path, Inc., the parent company which owns Hubble Contacts and ContactsCart, today named Rachael Durkin as Vice President of Marketing and Strategy.
  • As GM, she oversaw finance, design and product development, brand and performance marketing, creative, partnerships, merchandising and planning, website development, production, operations, supply chain, and customer service.
  • "Working for Hubble is exactly the kind of opportunity I was looking for as the next stage of my career," said Durkin.
  • Through its online platforms, Hubble sells contact lenses and eyeglasses under the Hubble brand.

WALDO Launches Doctor Partnership Program in the United States

Tuesday, November 30, 2021 - 3:30pm

WALDO, the innovative eyecare brand championing positive vision for all, is pleased to announce the launch of their doctor partnership program in the United States.

Key Points: 
  • WALDO, the innovative eyecare brand championing positive vision for all, is pleased to announce the launch of their doctor partnership program in the United States.
  • With their flexible subscription plans and innovative digital platform, WALDO patients stay compliant and up-to-date on their prescriptions.
  • When we launched WALDO, we had a clear vision: disrupt the eyecare industry and create the go-to, trusted eyecare brand for wearers and Optometrists, said Ashleigh Hinde, WALDO Founder and CEO.
  • Through innovative products, an insightful and thoughtful business philosophy and courage to push boundaries - WALDO strives to lead industry evolution.

Visus Therapeutics Announces Positive Topline Clinical Data from Phase 2 VIVID Study of BRIMOCHOL for the Treatment of Presbyopia

Tuesday, November 30, 2021 - 1:00pm

A minimum of 35% of subjects in the study met this same endpoint at nine hours in all three formulations.

Key Points: 
  • A minimum of 35% of subjects in the study met this same endpoint at nine hours in all three formulations.
  • Based on these positive outcomes, the company plans to commence Phase 3 pivotal trials shortly.
  • The successful completion of the VIVID study marks an important milestone for Visus Therapeutics, said Ben Bergo, co-founder and chief executive officer at Visus Therapeutics.
  • We are pleased the VIVID study data exceeded our expectations, demonstrating a clear opportunity to commercialize long-acting miotic formulations.

DGAP-News: Mister Spex SE continues double-digit growth in third quarter of 2021

Wednesday, November 24, 2021 - 7:01am

The contact lens revenues benefited from Mister Spex' leading price-value proposition in many markets.

Key Points: 
  • The contact lens revenues benefited from Mister Spex' leading price-value proposition in many markets.
  • Compared to the third quarter of 2019, Mister Spex grew strongly by 35%.
  • In addition to expanding its retail network, Mister Spex has recently also been able to further expand its product range.
  • The quarterly report and the results presentation for analysts and investors are available on the Mister Spex Investor Relations website .

HKTDC Lifestyle Sourcing Show opens next Wednesday

Tuesday, November 23, 2021 - 8:00am

The HKTDC is staging the HKTDC Lifestyle Sourcing Show, a trade exhibition held in both online and physical formats that will showcase the latest toys, baby products, gifts and premium, houseware, optical products and wines.

Key Points: 
  • The HKTDC is staging the HKTDC Lifestyle Sourcing Show, a trade exhibition held in both online and physical formats that will showcase the latest toys, baby products, gifts and premium, houseware, optical products and wines.
  • The physical edition of the Lifestyle Sourcing Show at the HKCEC will display a range of consumer and lifestyle goods and solutions in a showcase format.
  • The HKTDC debuted its online-and-physical sourcing model at the International Sourcing Show from March to July this year.
  • The Lifestyle Sourcing Show will highlight a broad range of quality lifestyle products and solutions under four themes.

GSK showcases progress from the DREAMM clinical trial program in multiple myeloma at the 2021 ASH Annual Meeting

Thursday, November 18, 2021 - 1:35pm

This pathway has been shown to be important for myeloma cell growth and survival.

Key Points: 
  • This pathway has been shown to be important for myeloma cell growth and survival.
  • Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).
  • Because of the risk of ocular toxicity, BLENREP is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the BLENREP REMS.
  • For patients in whom events resolved, the median time to resolution was 2 months (range: 11 days to 8.3 months).

Introducing Ray-Ban's Clubmaster in an Exclusive New Color, Available Only at GlassesUSA.com

Monday, November 15, 2021 - 2:00pm

This brand new style combines a transparent grey frame trend with silver metal for a stylish yet easy-to-wear combination suitable for men and women alike.

Key Points: 
  • This brand new style combines a transparent grey frame trend with silver metal for a stylish yet easy-to-wear combination suitable for men and women alike.
  • The frames will retail for $189 and only 1,000 pairs of the limited edition style will be produced.
  • The Clubmaster style confidently walks the line between old school and '80s excess and knows that vision is the first step in reshaping culture.
  • The leading optical retailer is always looking for ways to offer new and exclusive styles, as well as offer a VIP optical purchasing experience.

Bausch + Lomb Reports More Than 41 Million Units Of Contact Lens, Eye And Lens Care Materials Recycled Through ONE By ONE And Biotrue® Eye Care Recycling Programs

Monday, November 15, 2021 - 11:59am

As a result, contact lens, eye and lens care materials don't typically end up getting processed and are diverted to landfills.

Key Points: 
  • As a result, contact lens, eye and lens care materials don't typically end up getting processed and are diverted to landfills.
  • For more information on the ONE by ONE and Biotrue Eye Care Recycling programs, visit https://www.biotrue.com/recycling .
  • The Bausch + Lomb Biotrue Eye Care Recycling program isthe first and only eye care recycling program inthe United States.
  • The Bausch + Lomb ONE by ONE Recycling program is the first and only sponsored contact lens recycling program inthe United States.

Eyenovia Reports Third Quarter 2021 Financial Results

Wednesday, November 10, 2021 - 9:05pm

NEW YORK, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print (MAP™) platform technology, today announced its financial results for the third quarter ended September 30, 2021.

Key Points: 
  • Announced that Dr. Fred Eshelman, who has served as Chairman of the Eyenovia Board since 2014, will step down by the end of 2021 to pursue other professional interests.
  • On September 14, 2021, Arctic Vision and Eyenovia expanded an existing licensing agreement to include MydCombi.
  • Eyenovia now has a total of 13 patents for the technology in the United States and over 80 international patents.
  • For the third quarter of 2021, net loss was approximately$5.6 million, or$(0.21)per share, compared to a net loss of approximately$5.1 million, or$(0.23)per share, for the third quarter of 2020.